January 2006

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Biological: alemtuzumab;   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Biological: rituximab;   Biological: therapeutic allogeneic lymphocytes;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
Sponsor:   German CLL Study Group
Completed - verified April 2007

Hematopoietic Stem Cell Support in Vasculitis

Condition:   Vasculitis
Interventions:   Biological: Autologous Stem Cell Transplant;   Biological: Allogeneic Stem Cell Transplant
Sponsor:   Northwestern University
Terminated - verified July 2016